Rosacea can be unsettling, uncomfortable, and painful. MetroBoston is planning Rosacea Clinical Trials to understand the skin condition and find its potential treatments.
Rosacea Clinical Trials
Rosacea is a chronic skin condition that primarily affects the face, causing redness, flushing, and visible blood vessels. It can also cause pimples, bumps, and a thickening of the skin on the nose, leading to a condition called rhinophyma. Rosacea typically affects more women than men. The prevalence of rosacea is estimated to be around 1-10% worldwide. In the United States, it is estimated that rosacea affects approximately 16 million people. MetroBoston is conducting dermatology clinical trials to determine the safety and efficacy of potential new treatments that may improve Rosacea and therefore quality of life in those suffering from Rosacea.
Current Status:
Not Recruiting
Frequently Asked Questions
What is the duration of rosacea?
Rosacea is a chronic skin condition, which means that it persists over time and typically does not have a definitive duration.
Is rosacea a contagious disease?
No, rosacea is not a contagious disease. It is a chronic skin condition that affects the facial skin, causing visible blood vessels, and in some cases, acne-like breakouts.
Will rosacea get worse as a person gets older?
The progression and severity of rosacea can vary from person to person. While there is no definitive pattern for how rosacea will progress over time, it is generally observed that rosacea worsens with age if left untreated. Learn more about Rosacea Clinical Trials at MetroBoston.
Are there experimental trials being tested for rosacea?
Yes, there are ongoing Rosacea clinical trials in Boston focused on developing new treatments and understanding the underlying mechanisms of rosacea. These trials aim to evaluate the safety and effectiveness of potential therapies for rosacea.
What is the main cause of rosacea?
The exact cause of rosacea is not fully understood, however, it is believed to involve a combination of genetic, environmental, vascular, and inflammatory factors.
Have Queries?
Find out more about our clinical trials by dropping your message below.
617-789-5300